GAVI, the Vaccine Alliance, is set to buy 500,000 doses of the Bavarian Nordic Mpox vaccine as part of its efforts to tackle the outbreak in parts of Africa.
In a statement issued on Wednesday, GAVI said it made an advance purchase agreement to secure the shots and have them supplied to African countries affected by the outbreak of the Mpox virus.
According to the group, the vaccine purchase will be funded by GAVI’s first response fund, a new financial mechanism established to help secure funds for health emergencies in June.
